C
Originally published by Capital Newstop
February 26, 2026
1h ago
Kenya launches long-acting HIV prevention drug Lenacapavir

Health Cabinet Secretary Aden Duale presided over the launch at Riruta Health Centre in Nairobi, describing the rollout as a milestone that brings renewed hope to millions of Kenyans. The country currently has about 1.4 million people living with HIV, with thousands of new infect..
✨ Key Highlights
Kenya has launched Lenacapavir, a new long-acting injectable drug for HIV prevention, marking a significant advancement in managing the epidemic.
- The drug will be administered twice a year and provided free of charge to eligible individuals.
- This initiative was overseen by Health Cabinet Secretary Aden Duale and supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
- Kenya is one of the first countries globally to introduce this innovative prevention option, aiming to protect young people and reduce new infections.
Continue Reading
Read the complete article from Capital News
Advertisement
Related News
Advertisement





